Nadia Garcia-Moran

Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

HIV superinfection reveals sequential reservoir reactivation and immune-driven rebound dynamics.

HIV superinfection reveals sequential reservoir reactivation and immune-driven rebound dynamics.

Journal: Journal of virology

Published: July 10, 2026

T-Cell Responses to COVID-19 Vaccines and Breakthrough Infection in People Living with HIV Receiving Antiretroviral Therapy.

T-Cell Responses to COVID-19 Vaccines and Breakthrough Infection in People Living with HIV Receiving Antiretroviral Therapy.

Journal: Viruses

Published: March 20, 2024

Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size.

Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size.

Journal: AIDS (London, England)

Published: January 15, 2024

Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size.

Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size.

Journal: medRxiv : the preprint server for health sciences

Published: October 24, 2023

Antibody response durability following three-dose coronavirus disease 2019 vaccination in people with HIV receiving suppressive antiretroviral therapy.

Antibody response durability following three-dose coronavirus disease 2019 vaccination in people with HIV receiving suppressive antiretroviral therapy.

Journal: AIDS (London, England)

Published: December 22, 2022

SARS CoV-2 mRNA vaccination exposes latent HIV to Nef-specific CD8+ T-cells.

SARS CoV-2 mRNA vaccination exposes latent HIV to Nef-specific CD8+ T-cells.

Journal: Nature communications

Published: June 06, 2022

People with HIV receiving suppressive antiretroviral therapy show typical antibody durability after dual COVID-19 vaccination, and strong third dose responses.

People with HIV receiving suppressive antiretroviral therapy show typical antibody durability after dual COVID-19 vaccination, and strong third dose responses.

Journal: medRxiv : the preprint server for health sciences

Published: March 30, 2022

People With Human Immunodeficiency Virus Receiving Suppressive Antiretroviral Therapy Show Typical Antibody Durability After Dual Coronavirus Disease 2019 Vaccination and Strong Third Dose Responses.

People With Human Immunodeficiency Virus Receiving Suppressive Antiretroviral Therapy Show Typical Antibody Durability After Dual Coronavirus Disease 2019 Vaccination and Strong Third Dose Responses.

Journal: The Journal of infectious diseases

Published: March 23, 2022

Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy.

Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy.

Journal: medRxiv : the preprint server for health sciences

Published: October 21, 2021

Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy.

Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy.

Journal: NPJ vaccines

Published: October 15, 2021

Showing 1-10 of 10

Last Updated: 09/26/2026